TLB, OXGN, FSLR - CRWESelect Stock News! The Talbots, OXiGENE, First Solar (Video Included Inside)

FOR IMMEDIATE RELEASE
Las Vegas, Nevada, United States of America (Free-Press-Release.com) December 7, 2011 -- To view video, and read the full article visit URL http://crweselect.com/27672/stock-alerts/tlb-oxgn-fslr-crweselect-stock-news-the-talbots-oxigene-first-solar-video-included-inside/

The Talbots, Inc. (NYSE:TLB)

TLB announced today that its Board of Directors has received an unsolicited letter, dated December 6, 2011, from Sycamore Partners outlining a non-binding proposal to acquire all of the Company’s outstanding common stock for $3.00 per share. The Board, in consultation with its external legal and financial advisors, Dewey & LeBoeuf LLP and Perella Weinberg Partners, intends to evaluate the proposal consistent with its fiduciary duties to act in the best interest of the Company’s stockholders.

TLB is a leading specialty retailer and direct marketer of women’s apparel, shoes and accessories. At the end of the third quarter 2011, the Company operated 551 Talbots stores in 46 states and Canada.

For more information about TLB please visit http://www.talbots.com

****

OXiGENE, Inc. (NASDAQ:OXGN)

OXGN announced today that Dr. Timothy Lai, MD, FRCS, FRCOphth, Honorary Clinical Associate Professor of Ophthalmology from the Chinese University of Hong Kong, presented encouraging data from the FAVOR study of ZYBRESTAT in polypoidal choroidal vasculopathy (PCV) at the 6th Asia-Pacific VitreoRetina Society (APVRS) Congress in Hyderabad, India on December 2, 2011. FAVOR is a Phase 2 study investigating the use of a single intravenous injection of ZYBRESTAT at different doses compared to placebo in patients with PCV, followed by imaging of the retina on days 2, 8, 15, and 28. PCV is a potentially blinding eye disease that involves the growth of tiny, abnormal blood vessels under the retina. The data showed that ZYBRESTAT was well tolerated in the study.

OXGN, a clinical-stage biopharmaceutical company, develops novel therapeutics to treat cancer and eye diseases in the United States.

For more information about OXGN please visit http://www.oxigene.com

****

First Solar, Inc. (NASDAQ:FSLR)

MidAmerican Energy Holdings Company announced it has entered into definitive agreements to acquire the Topaz Solar Farm from FSLR - The 550-megawatt photovoltaic power plant being built in San Luis Obispo County, Calif., will have the capacity to generate enough renewable energy to power approximately 160,000 average California homes. The more than $2 billion Topaz project is one of the two largest PV projects in the world, both being built by First Solar.

FSLR manufactures solar modules with an advanced semiconductor technology and is a premier provider of comprehensive photovoltaic system solutions. The company is delivering an economically viable alternative to fossil-fueled generation. From raw material sourcing through end-of-life collection and recycling, First Solar is focused on creating value-driven renewable energy solutions that protect and enhance the environment.

For more information about FSLR please visit http://www.firstsolar.com

To read the full article visit URL http://crweselect.com/27672/stock-alerts/tlb-oxgn-fslr-crweselect-stock-news-the-talbots-oxigene-first-solar-video-included-inside/

*****************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWESelect.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers.Our disclaimer( http://crweselect.com/disclaimer/) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWESelect.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a media-advertisement and newswire company. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock.Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.

TLBcrweselect1207
OXGNcrweselect1207
FSLRcrweselect1207

First Solar     FSLR     MidAmerican Energy Holdings     OXGN     OXiGENE     The Talbots     TLB     ZYBRESTAT